Around 40 medicines that have already been registered in Pakistan remain unavailable to patients because the federal government has yet to approve their prices. The delay has left thousands of patients, including those battling cancer, diabetes and other life-threatening diseases, with limited treatment options, forcing many to depend on costly personal imports or smuggled and unregistered medi